{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T12:54:17Z","timestamp":1768568057500,"version":"3.49.0"},"reference-count":25,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T00:00:00Z","timestamp":1642377600000},"content-version":"unspecified","delay-in-days":16,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2021,11,8]]},"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Due to the increased use of CT and MRI, the prevalence of incidental findings on brain scans is increasing. Meningioma, the most common primary brain tumour, is a frequently encountered incidental finding, with an estimated prevalence of 3\/1000. The management of incidental meningioma varies widely with active clinical-radiological monitoring being the most accepted method by clinicians. Duration of monitoring and time intervals for assessment, however, are not well defined. To this end, we have recently developed a statistical model of progression risk based on single-centre retrospective data. The model Incidental Meningioma: Prognostic Analysis Using Patient Comorbidity and MRI Tests (IMPACT) employs baseline clinical and imaging features to categorise the patient with an incidental meningioma into one of three risk groups: low, medium and high risk with a proposed active monitoring strategy based on the risk and temporal trajectory of progression, accounting for actuarial life expectancy. The primary aim of this study is to assess the external validity of this model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>IMPACT is a retrospective multicentre study which will aim to include 1500 patients with an incidental intracranial meningioma, powered to detect a 10% progression risk. Adult patients \u226516 years diagnosed with an incidental meningioma between 1 January 2009 and 31 December 2010 will be included. Clinical and radiological data will be collected longitudinally until the patient reaches one of the study endpoints: intervention (surgery, stereotactic radiosurgery or fractionated radiotherapy), mortality or last date of follow-up. Data will be uploaded to an online Research Electronic Data Capture database with no unique identifiers. External validity of IMPACT will be tested using established statistical methods.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>Local institutional approval at each participating centre will be required. Results of the study will be reported through peer-reviewed articles and conferences and disseminated to participating centres, patients and the public using social media.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2021-052705","type":"journal-article","created":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T12:09:36Z","timestamp":1642507776000},"page":"e052705","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":9,"title":["External validation and recalibration of an incidental meningioma prognostic model \u2013 IMPACT: protocol for an international multicentre retrospective cohort study"],"prefix":"10.1136","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9621-043X","authenticated-orcid":false,"given":"Abdurrahman I","family":"Islim","sequence":"first","affiliation":[{"name":"Institute of Systems, Molecular & Integrative Biology, University of Liverpool, Liverpool, UK"},{"name":"Department of Neurosurgery, The Walton Centre NHS Foundation Trust, Liverpool, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7727-1157","authenticated-orcid":false,"given":"Christopher P","family":"Millward","sequence":"additional","affiliation":[{"name":"Institute of Systems, Molecular & Integrative Biology, University of Liverpool, Liverpool, UK"},{"name":"Department of Neurosurgery, The Walton Centre NHS Foundation Trust, Liverpool, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rory J","family":"Piper","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel M","family":"Fountain","sequence":"additional","affiliation":[{"name":"Manchester Centre for Clinical Neurosciences, Salford Royal NHS Foundation Trust, Salford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaveta","family":"Mehta","sequence":"additional","affiliation":[{"name":"Institute of Systems, Molecular & Integrative Biology, University of Liverpool, Liverpool, UK"},{"name":"Department of Clinical Oncology, The Clatterbridge Cancer Centre NHS Foundation Trust, Wirral, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3886-6208","authenticated-orcid":false,"given":"Ruwanthi","family":"Kolamunnage-Dona","sequence":"additional","affiliation":[{"name":"Department of Health Data Science, Institute of Population Health, University of Liverpool, Liverpool, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Usama","family":"Ali","sequence":"additional","affiliation":[{"name":"Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shelli Diane","family":"Koszdin","sequence":"additional","affiliation":[{"name":"Veterans Affairs Healthcare System, Palo Alto, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theo","family":"Georgious","sequence":"additional","affiliation":[{"name":"Brain Tumor Charity, Fleet, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samantha J","family":"Mills","sequence":"additional","affiliation":[{"name":"Department of Neuroradiology, The Walton Centre NHS Foundation Trust, Liverpool, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew R","family":"Brodbelt","sequence":"additional","affiliation":[{"name":"Institute of Systems, Molecular & Integrative Biology, University of Liverpool, Liverpool, UK"},{"name":"Department of Neurosurgery, The Walton Centre NHS Foundation Trust, Liverpool, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2609-9876","authenticated-orcid":false,"given":"Ryan K","family":"Mathew","sequence":"additional","affiliation":[{"name":"Leeds Institute of Medical Research at St James\u2019s, University of Leeds School of Medicine, Leeds, UK"},{"name":"Department of Neurosurgery, Leeds Teaching Hospitals NHS Trust, Leeds, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Santarius","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Addenbrooke\u2019s Hospital, Cambridge, UK"},{"name":"Division of Neurosurgery, University of Cambridge School of Clinical Medicine, Cambridge, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael D","family":"Jenkinson","sequence":"additional","affiliation":[{"name":"Institute of Systems, Molecular & Integrative Biology, University of Liverpool, Liverpool, UK"},{"name":"Department of Neurosurgery, The Walton Centre NHS Foundation Trust, Liverpool, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2022,1,18]]},"reference":[{"key":"2025121400592254000_12.1.e052705.1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000338081","article-title":"Epidemiology of meningioma in the United Kingdom","volume":"39","author":"Cea-Soriano","year":"2012","journal-title":"Neuroepidemiology"},{"key":"2025121400592254000_12.1.e052705.2","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noz150"},{"key":"2025121400592254000_12.1.e052705.3","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b3016"},{"key":"2025121400592254000_12.1.e052705.4","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.wneu.2017.06.127","article-title":"Trends in management of intracranial meningiomas: analysis of 49,921 cases from modern cohort","volume":"106","author":"Agarwal","year":"2017","journal-title":"World Neurosurg"},{"key":"2025121400592254000_12.1.e052705.5","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30321-7"},{"key":"2025121400592254000_12.1.e052705.6","unstructured":"National Comprehensive Cancer Network . NCCN clinical practice guidelines in Oncology-Central nervous system cancer (version 1.2017). Available: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/cns.pdf [Accessed 11 Nov 2017]."},{"key":"2025121400592254000_12.1.e052705.7","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-019-03104-3"},{"key":"2025121400592254000_12.1.e052705.8","doi-asserted-by":"publisher","DOI":"10.1007\/s00701-018-3554-4"},{"key":"2025121400592254000_12.1.e052705.9","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1055\/s-0034-1543959","article-title":"Will an asymptomatic meningioma grow or not grow? A meta-analysis","volume":"76","author":"Zeng","year":"2015","journal-title":"J Neurol Surg A Cent Eur Neurosurg"},{"key":"2025121400592254000_12.1.e052705.10","first-page":"438","article-title":"A prospective study of the natural history of incidental meningioma-Hold your horses!","volume":"6","author":"Behbahani","year":"2019","journal-title":"Neurooncol Pract"},{"key":"2025121400592254000_12.1.e052705.11","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1093\/neuonc\/noz160","article-title":"A prognostic model to personalize monitoring regimes for patients with incidental asymptomatic meningiomas","volume":"22","author":"Islim","year":"2020","journal-title":"Neuro Oncol"},{"key":"2025121400592254000_12.1.e052705.12","first-page":"370","article-title":"American joint Committee on cancer acceptance criteria for inclusion of risk models for individualized prognosis in the practice of precision medicine","volume":"66","author":"Kattan","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"2025121400592254000_12.1.e052705.13","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.jocn.2007.06.001","article-title":"Peritumoral edema and prognosis in intracranial meningioma surgery","volume":"15","author":"Vignes","year":"2008","journal-title":"J Clin Neurosci"},{"key":"2025121400592254000_12.1.e052705.14","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000004705","article-title":"Lessons from surgical outcome for intracranial meningioma involving major venous sinus","volume":"95","author":"Han","year":"2016","journal-title":"Medicine"},{"key":"2025121400592254000_12.1.e052705.15","doi-asserted-by":"publisher","DOI":"10.1227\/01.NEU.0000365366.53337.88"},{"key":"2025121400592254000_12.1.e052705.16","doi-asserted-by":"publisher","DOI":"10.3171\/JNS-07\/08\/0325"},{"key":"2025121400592254000_12.1.e052705.17","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1001\/jamaoncol.2015.3113","article-title":"Performance status in patients with cancer","volume":"1","author":"West","year":"2015","journal-title":"JAMA Oncol"},{"key":"2025121400592254000_12.1.e052705.18","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-007-0130-7"},{"key":"2025121400592254000_12.1.e052705.19","doi-asserted-by":"publisher","DOI":"10.1016\/0895-4356(94)90129-5"},{"key":"2025121400592254000_12.1.e052705.20","unstructured":"The Cancer Imaging Archive . Wiki for the VASARI feature set. The National cancer Institute, 2015. Available: https:\/\/wiki.cancerimagingarchive.net\/display\/Public\/VASARI+Research+Project [Accessed 06 Jan 2018]."},{"key":"2025121400592254000_12.1.e052705.21","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.20.1.22"},{"key":"2025121400592254000_12.1.e052705.22","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-016-1545-1"},{"key":"2025121400592254000_12.1.e052705.23","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.wneu.2010.11.010","article-title":"A new classification of complications in neurosurgery","volume":"75","author":"Landriel Iba\u00f1ez","year":"2011","journal-title":"World Neurosurg"},{"key":"2025121400592254000_12.1.e052705.24","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1177\/0962280216673084","article-title":"Time-Dependent efficacy of longitudinal biomarker for clinical endpoint","volume":"27","author":"Kolamunnage-Dona","year":"2018","journal-title":"Stat Methods Med Res"},{"key":"2025121400592254000_12.1.e052705.25","doi-asserted-by":"publisher","DOI":"10.1002\/sim.3451"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2021-052705","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T08:59:29Z","timestamp":1765702769000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2021-052705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,1,18]]},"published-print":{"date-parts":[[2022,1]]}},"alternative-id":["10.1136\/bmjopen-2021-052705"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2021-052705","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1]]}}}